- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow ONTARGET Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 134000 [Title] => Study centers in 40 countries involved in heart pr [Summary] => A total of 793 study centers in 40 countries have been recruited to enroll 28,400 patients over two years for the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) cardiovascular protection trial.
Boehringer Ingelheim, one of the worlds leading pharmaceutical companies, announced this at the European Society of Cardiology Congress in Stockholm, Sweden.
[DatePublished] => 2001-09-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 83550 [Title] => Boehringer Ingelheim sets largest cardiovascular protection trial [Summary] => MILAN, Italy Boehringer Ingelheim has announced plans for the largest cardiovascular protection trial ever conducted on patients intolerant to angiotensin converting enzyme (ACE) inhibitors.
The study, announced at the European Society of Hypertension meeting, will examine the effects of the angiotensin III recepto antagonist (ARB) Micardis or telmisartan, on these patients. About 5,000 patients worldwide will be enrolled in the study.
[DatePublished] => 2001-06-18 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
ONTARGET
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 134000 [Title] => Study centers in 40 countries involved in heart pr [Summary] => A total of 793 study centers in 40 countries have been recruited to enroll 28,400 patients over two years for the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) cardiovascular protection trial.
Boehringer Ingelheim, one of the worlds leading pharmaceutical companies, announced this at the European Society of Cardiology Congress in Stockholm, Sweden.
[DatePublished] => 2001-09-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 83550 [Title] => Boehringer Ingelheim sets largest cardiovascular protection trial [Summary] => MILAN, Italy Boehringer Ingelheim has announced plans for the largest cardiovascular protection trial ever conducted on patients intolerant to angiotensin converting enzyme (ACE) inhibitors.
The study, announced at the European Society of Hypertension meeting, will examine the effects of the angiotensin III recepto antagonist (ARB) Micardis or telmisartan, on these patients. About 5,000 patients worldwide will be enrolled in the study.
[DatePublished] => 2001-06-18 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
September 17, 2001 - 12:00am
June 18, 2001 - 12:00am
Recommended
Mapua captain Clint Escamis has made known to everyone that he only wants one thing – win the NCAA senior basketball championship.
8 hours ago
Adamson took care of business against Ateneo, 69-55, and dragged University of the East into a playoff for the last semifinals ticket in the UAAP Season 87 men’s basketball yesterday at the Filoil EcoOil Centre in San Juan.
8 hours ago
It took over a year before PBA vice chairman Alfrancis Chua agreed to reprise his role as Gilas team manager and with the added responsibility as Gilas project director, he’s ready to do his share in bringing the country’s national basketball program to new heights.
8 hours ago
Still alive.
11 hours ago
University of Santo Tomas and Adamson are heading into the UAAP Season 87 women’s basketball semifinals on a high after defeating their respective opponents Saturday at the FilOil EcoOil Centre in San Juan.
17 hours ago
Lotto Nov 23, 2024
EZ2/LVM - 7 25
SUERTRES - 0 8 2
6D Lotto - 2 3 1 5 7 1
6/42 - 18 2 40 42 26 14
P13,275,319.00
Grand Lotto - 4 17 26 9 41 7
P29,700,000.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66